Shelter Pharma Ltd
₹ 53.1
3.47%
22 Nov
- close price
About
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including
food supplements for animals[1]
Key Points
- Market Cap ₹ 61.4 Cr.
- Current Price ₹ 53.1
- High / Low ₹ 80.9 / 41.1
- Stock P/E 9.21
- Book Value ₹ 34.0
- Dividend Yield 0.62 %
- ROCE 31.6 %
- ROE 25.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.9%
Cons
- Promoter holding has decreased over last quarter: -1.92%
- Debtor days have increased from 61.0 to 80.7 days.
- Working capital days have increased from 140 days to 212 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 40.02 | 44.77 | |
| 27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28.90 | 31.44 | 35.58 | |
| Operating Profit | 0.15 | -0.70 | 0.24 | 0.19 | 3.05 | 7.25 | 8.58 | 9.19 |
| OPM % | 0.53% | -2.34% | 0.80% | 0.85% | 10.15% | 20.06% | 21.44% | 20.53% |
| -0.00 | 0.83 | 0.01 | 0.01 | -0.00 | -0.07 | -0.00 | 0.00 | |
| Interest | -0.00 | -0.00 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.07 |
| Depreciation | 0.10 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.23 |
| Profit before tax | 0.05 | 0.06 | 0.11 | 0.06 | 2.80 | 6.99 | 8.28 | 8.89 |
| Tax % | 20.00% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | |
| 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.20 | 6.66 | |
| EPS in Rs | 1.10 | 1.10 | 1.76 | 0.83 | 42.56 | 6.73 | 5.36 | 5.76 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 21% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 440% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 27.76 |
| 2.07 | 0.11 | 0.24 | -0.00 | 0.13 | 1.78 | 0.57 | 1.11 | |
| 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.52 | 2.55 | |
| Total Liabilities | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 42.98 |
| 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 4.37 | |
| CWIP | 0.14 | 0.11 | -0.00 | -0.00 | 0.55 | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | 0.68 | 0.68 | 0.68 | -0.00 | -0.00 | 0.68 |
| 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 37.93 | |
| Total Assets | 11.56 | 11.64 | 10.63 | 10.20 | 12.84 | 21.45 | 37.91 | 42.98 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| -0.00 | -0.27 | -0.28 | 0.52 | -0.00 | -1.85 | ||
| -0.00 | 0.29 | 0.03 | -0.85 | 0.11 | -4.54 | ||
| -0.00 | -0.00 | 0.48 | 0.06 | 0.21 | 11.01 | ||
| Net Cash Flow | -0.00 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 12.99 | 14.14 | 7.40 | 12.34 | 19.55 | 82.69 | 80.72 |
| Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 110.68 | 125.33 |
| Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 |
| Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.40 | 95.09 | 186.84 | 197.08 |
| Working Capital Days | 91.35 | 59.59 | 57.05 | 74.85 | 72.49 | 134.69 | 211.59 |
| ROCE % | 0.68% | 1.12% | 35.91% | 56.14% | 31.60% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
14 Nov - Resignation of Company Secretary effective November 13, 2024.
-
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended September 2024
30 Oct - Non-applicability of Regulation 23(9) for half year.
- Approval Of Standalone Unaudited Financial Result For The Half Year Ended On 30Th September, 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations, 2015 Along With Limited Review Report 30 Oct
-
Board Meeting Outcome for Approval Of Standalone Unaudited Financial Result For The Half Year Ended On 30Th September, 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations, 2015 Along With Limited Review Report
30 Oct - Approval of unaudited financial results for H1 2024.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
29 Oct - Shelter Pharma secures $6,700 order from FIRSTVET.
Business Overview:[1]
SPL is a GMP & HACCP certified and ISO 9001:2015 certified manufacturer and seller of a range of herbal Ayurvedic medicines in India for humans and food supplements for animals